Suppr超能文献

健康人体重复摄入乙醇过程中尿中乙基葡萄糖醛酸苷和5-羟色醇水平

Urinary ethyl glucuronide and 5-hydroxytryptophol levels during repeated ethanol ingestion in healthy human subjects.

作者信息

Sarkola Taisto, Dahl Helen, Eriksson C J Peter, Helander Anders

机构信息

Department of Mental Health and Alcohol Research, National Public Health Institute, POB 33, FIN-00251 Helsinki, Finland.

出版信息

Alcohol Alcohol. 2003 Jul-Aug;38(4):347-51. doi: 10.1093/alcalc/agg083.

Abstract

AIMS

This study investigated the stability and reproducibility of urinary ethyl glucuronide (EtG) and the 5-hydroxytryptophol (5-HTOL) to 5-hydroxyindole-3-acetic acid (5-HIAA) ratio, both of which are used as biochemical markers of recent alcohol consumption, after single and multiple oral doses of ethanol in healthy human subjects.

METHODS

Nine females aged 19-27 years drank ethanol (8%, w/v, in juice) or placebo (juice) in random order. The intervention consisted of 0.4 g/kg (22-28 g) of ethanol or placebo twice daily (in the morning and evening) during 8 consecutive days, starting in the evening on day 1. Spot urine samples of the first morning void were collected during the 8-day drinking period and for another 3 days (days 9-11) with no intake of ethanol or placebo. Ethanol, EtG, 5-HTOL and 5-HIAA were determined in the urine samples by headspace GC, LC-MS, GC-MS and HPLC, respectively.

RESULTS

The individual results during the drinking period were highly variable, both within and between subjects, ranging from 0-7.3 mmol/l for ethanol, 1.4-71.0 mg/l for EtG, 0.1-4.5 mg/mmol for the EtG/creatinine ratio, and 2-109 nmol/ micro mol for 5-HTOL/5-HIAA. The placebo group consistently showed negative values for ethanol (< 0.1 mmol/l) and 5-HTOL/5-HIAA (< 15 nmol/ micro mol), but two samples were positive for EtG (> 0.1 mg/l). In the morning of day 9 (i.e. approximately 14-15 h after the last dose), ethanol was no longer measurable in urine and the 5-HTOL/5-HIAA ratio had returned to below the reference value, but detectable levels of EtG (11.3 +/- 6.0 mg/l, mean +/- SD) and the EtG/creatinine ratio (1.0 +/- 0.3 mg/mmol) were found in all samples.

CONCLUSIONS

The results confirm the increase in urinary EtG and 5-HTOL levels during acute ethanol intake, although the individual values were highly variable both within and between subjects. No significant accumulation of either compound occurred upon multiple-dose administration of 0.8 g/kg (44-57 g) ethanol per day for approximately 1 week.

摘要

目的

本研究调查了健康人体受试者单次和多次口服乙醇后,尿中乙基葡萄糖醛酸苷(EtG)以及5-羟色醇(5-HTOL)与5-羟吲哚-3-乙酸(5-HIAA)比值的稳定性和可重复性,这两者均用作近期饮酒的生化标志物。

方法

9名年龄在19至27岁之间的女性按随机顺序饮用乙醇(果汁中8%,w/v)或安慰剂(果汁)。干预措施为连续8天每天两次(早晚)服用0.4 g/kg(22 - 28 g)乙醇或安慰剂,从第1天晚上开始。在8天饮酒期间以及另外3天(第9 - 11天)不摄入乙醇或安慰剂时,收集每天晨尿的即时尿样。分别采用顶空气相色谱法、液相色谱 - 质谱法、气相色谱 - 质谱法和高效液相色谱法测定尿样中的乙醇、EtG、5-HTOL和5-HIAA。

结果

饮酒期间个体结果在受试者内部和受试者之间差异很大,乙醇浓度范围为0 - 7.3 mmol/l,EtG为1.4 - 71.0 mg/l,EtG/肌酐比值为0.1 - 4.5 mg/mmol,5-HTOL/5-HIAA为2 - 109 nmol/μmol。安慰剂组乙醇(< 0.1 mmol/l)和5-HTOL/5-HIAA(< 15 nmol/μmol)始终显示为负值,但有两个样本EtG呈阳性(> 0.1 mg/l)。在第9天早晨(即最后一剂后约14 - 15小时),尿中不再可检测到乙醇,5-HTOL/5-HIAA比值已恢复至参考值以下,但所有样本中均检测到可检测水平的EtG(11.3 ± 6.0 mg/l,均值 ± 标准差)和EtG/肌酐比值(1.0 ± 0.3 mg/mmol)。

结论

结果证实急性乙醇摄入期间尿中EtG和5-HTOL水平升高,尽管个体值在受试者内部和受试者之间差异很大。每天多次服用0.8 g/kg(44 - 57 g)乙醇约1周后,两种化合物均未出现明显蓄积。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验